In August 2016, German pharmaceutical company Fresenius Kabi announced a proposal to expand its pharmaceutical manufacturing capabilities at the Melrose Park village site in Illinois, US.
4 May 2018 projects
8 February 2018 News
A heart attack drug manufactured by AstraZeneca has been shown to significantly reduce the risk of further cardiovascular (CV) events in people who have survived a heart attack, according to...
16 January 2018 projects
Leading Switzerland-based biopharmaceuticals supplier Lonza and French life sciences firm Sanofi has established a joint venture (JV) to set up a large-scale biologics production facility in Visp, Switzerland.
5 January 2018 projects
SCA Pharmaceuticals officially opened a new manufacturing facility in Windsor, Connecticut, on 27 November 2017.
20 July 2017 projects
Japanese drug maker, Takeda Pharmaceutical Company, inaugurated a new pharmaceutical production facility at its existing site in Oranienburg town, Brandenburg, Germany, in June 2017.
4 July 2017 projects
Hanmi Pharmaceutical is constructing a new biologics manufacturing facility in the city of Pyeongtaek in the Gyeonggi province of South Korea.
11 May 2017 projects
UK-Swedish pharmaceutical and biologics company AstraZeneca is building a new global R&D centre and corporate headquarters on the Cambridge Biomedical Campus (CBC) in Cambridge, UK.